HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 2 of 2
Allo CD7 CAR WU-CART-007
The purpose of this study is to determine the safety and tolerability of an experimental form of therapy, known as WU-CART-007 (“study drug”).
Related PI: Shannon L. Maude, MD, PhD
Phase 1 Trial of CUDC-907
The overall goals of this study are to evaluate the side effects and benefits of CUDC-907 in patients with relapsed or treatment refractory solid tumor, brain tumor, or lymphoma, and to determine the best dose of CUDC-907 for children and adolescents.
Related PI: Frank M. Balis, MD
Related Conditions: Oncology, Pediatric Solid Tumors, Solid Tumors, Brain Tumors, Lymphoma